Oncology Market - Forecast(2019 - 2024)

Report Code: HCR 1226 Report Format: PDF + Excel Database
Oncology Market Overview:
 
According to the UK based Cancer Research Institute, different types of cancer were responsible for around 9.6 million deaths in the world in the year 2018. Additionally, approximately 18 million cases of cancer were reported in the same year.[1] Cancer has always been one of the most intimidating diseases in the world with a high chance of fatality. Detrimental lifestyle changes are responsible for consistently rising statistics of cancer patients in the world, which in turn has generated a high demand for the oncology market. Oncology has been fundamental in the prevention of cancer throughout the world because of advanced diagnosis, and timely prevention to lessen exposure to tobacco, smoking, and consumption of alcohol. 
 
The oncology market will witness remarkable growth in the upcoming years with the increase in disposable income, booming medical technology sector, and elevated demand for cancer treatment. During the forecast period of 2019-2025, the market is expected to grow with a burgeoning compound annual growth rate (CAGR) of 12.6%. In 2018, the size of the global market was estimated at $120 billion.
 
Oncology Market Outlook:
 
Oncology, to put simply is the study of cancer- its causes, its symptoms, diagnosis, and treatment. Detection of cancer is not as difficult as it used to be because of oncology, and this branch aims to educate people about the potential dangers of this disease and how as a society, humans can take small steps towards eradicating it. Home to the eminent Cancer Research Institute, a US-based non-profitable organization, North America was the geographical leader of the global oncology market. In the year 2018, it held a regional market share of 46%. There are different kinds of oncology including medical oncology which makes the use of medicines or chemotherapy, surgical oncology, in which the surgeon removes the tumor from the tissue and radiation oncology which utilizes radiation therapy. The application segment of chemotherapy is expected to expand at an outstanding CAGR of 13.6 % during the forecast period of 2019-2025. 
 
Oncology Market Growth Drivers:
 
  • Harmful Lifestyle Patterns Contributing To Global Prevalence of Cancer
According to National Center For Biotechnology Information (NCBI), majority of the diagnosed cancer cases can be related to harmful lifestyles that patients have led in the past. A sedentary lifestyle, eating an unhealthy diet, excessive tobacco usage are some of the leading causes for cancer. Such factors are contributing to the growth of oncology and resulting in developments in the field. This is providing impetus to the market and allowing it thrive organically.
 
  • Government Initiatives For Cancer Prevention
Governments around the world are trying to fight cancer through several initiatives that they have begun for spreading awareness on cancer prevention. Center for Disease Control and Prevention in United States of America has started some significant initiatives such as Screen for Life: National Colorectal Cancer Action Campaign for colorectal campaign, Inside Knowledge Campaign for gynecologic cancer, Youth Risk Behavior Surveillance System and National Health Interview Survey for skin cancer, and many others. These initiatives highly rely on the branch of oncology and use most of its findings and research, providing impetus to the oncology market and generating demand.
 
Oncology Market Challenges: 
 
Cancer is an expensive disease and treatment is not accessible for people of all economic backgrounds. Because of limited information, in a lot of cases, cancer remains undetected. These are some of the challenges faced by the oncology market and can be combated only on creating inexpensive treatment methods for the general public.
 
Oncology Market Key Players Perspective:
 
Some of the key market players of the oncology market are F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb, Novartis AG, Pfizer, Sanofi, Amgen Inc., Johnson & Johnson, AstraZeneca PLC, AbbVie Inc., Astellas Pharma Inc., and Exelixis, Inc. 
 
Novartis AG, one the of world’s leading pharmaceutical companies is researching extensively in oncology in its Novartis Institutes for BioMedical Research (NIBR) and introducing new forms of treatment in the market like experimental gene therapy.
 
Oncology Market Trends:
 
  • With consistent technological advancement, the oncology market is experiencing immense innovation and making cancer diagnostics, and treatment of cancer easier.
  • The iKnife- Researchers have developed a surgical instrument called the iKnife that is a knife that can instantly figure out whether a particular set of cells is cancerous or not. When cutting through a tissue, the knife releases a specific type of smoke that is used for cancer detection.
  • Medical Robots- Doctors around the world are repeatedly handing over the incision part of a surgery to medical robots, thanks to automation. This segment of the surgery which has a high chance of mistake is carefully handed by these robots to offer tremor-free surgeries, thus resulting in high rates of successful surgery.
  • CAR T-Cell Therapy- While still in its budding stages, this form of immunotherapy is gaining immense popularity amongst patients suffering from leukemia. A patient’s blood is collected in this procedure and genetically modified by adding Chimeric Antigen Receptors (CARs) in the blood and left to expand. When the blood is sufficiently full of CARs, the blood is then transferred to the patient’s body. CARs present in the blood begin to attack the tumor cells, thus curing a patient’s cancer without any external procedures like chemotherapy or radiation therapy.
 
Oncology Market Research Scope 
 
The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the Oncology Market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of cheese in the Oncology Market, and their specific applications in different areas.
 
Oncology Market Report: Industry Coverage
 
The oncology market can be segmented on the basis of type and therapy type. On the basis of type, the market can be bifurcated into breast Cancer, lung Cancer, blood cancer, brain cancer, and others. On the basis of therapy type, the market can be divided into medical oncology, radiation oncology, and surgical oncology.
 
The Oncology Market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:
 
  • North America: The U.S., Canada, Mexico
  • South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica
  • Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark
  • APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong
  • Middle East and Africa: Israel, South Africa, Saudi Arabia

Reference:

[1] https://www.cancerresearchuk.org/health-professional/cancer-statistics/worldwide-cancer
1. Oncology Market - Overview
1.1. Definitions and Scope
2. Oncology Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Oncology Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Oncology Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Oncology Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Oncology Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Oncology Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Oncology Market – BY CANCER TYPE (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Introduction
8.3.2. Breast Cancer
8.3.3. Lung Cancer
9. Oncology Market – BY THERAPY TYPE (Market Size -$Million / $Billion)
9.1. Introduction
9.2. Medical Oncology
9.2.1. Chemotherapy
9.2.2. Targeted Therapy
9.2.3. Immunotherapy (biologics therapy)
9.2.4. Hormonal Therapy
9.2.5. Others 
9.2.5.1. Blood and Platelet Transfusions
9.2.5.2. Investigational Therapy
9.2.6. Radiation Oncology
9.2.6.1. External Radiation Therapy
9.2.6.2. internal Radiation Therapy
9.2.7. Surgical Oncology
9.2.7.1. Laparoscopic Surgery
9.2.7.2. Robotic Surgery
10. Oncology - By Geography (Market Size -$Million / $Billion)
10.1. Oncology Market - North America Segment Research
10.2. North America Market Research (Million / $Billion)
10.2.1. Segment type Size and Market Size Analysis 
10.2.2. Revenue and Trends
10.2.3. Application Revenue and Trends by type of Application
10.2.4. Company Revenue and Product Analysis
10.2.5. North America Product type and Application Market Size
10.2.5.1. U.S.
10.2.5.2. Canada 
10.2.5.3. Mexico 
10.2.5.4. Rest of North America
10.3. Oncology - South America Segment Research
10.4. South America Market Research (Market Size -$Million / $Billion)
10.4.1. Segment type Size and Market Size Analysis 
10.4.2. Revenue and Trends
10.4.3. Application Revenue and Trends by type of Application
10.4.4. Company Revenue and Product Analysis
10.4.5. South America Product type and Application Market Size
10.4.5.1. Brazil  
10.4.5.2. Venezuela
10.4.5.3. Argentina
10.4.5.4. Ecuador
10.4.5.5. Peru
10.4.5.6. Colombia 
10.4.5.7. Costa Rica
10.4.5.8. Rest of South America
10.5. Oncology - Europe Segment Research
10.6. Europe Market Research (Market Size -$Million / $Billion)
10.6.1. Segment type Size and Market Size Analysis 
10.6.2. Revenue and Trends
10.6.3. Application Revenue and Trends by type of Application
10.6.4. Company Revenue and Product Analysis
10.6.5. Europe Segment Product type and Application Market Size
10.6.5.1. U.K  
10.6.5.2. Germany 
10.6.5.3. Italy 
10.6.5.4. France
10.6.5.5. Netherlands
10.6.5.6. Belgium
10.6.5.7. Spain
10.6.5.8. Denmark
10.6.5.9. Rest of Europe
10.7. Oncology – APAC Segment Research
10.8. APAC Market Research (Market Size -$Million / $Billion)
10.8.1. Segment type Size and Market Size Analysis 
10.8.2. Revenue and Trends
10.8.3. Application Revenue and Trends by type of Application
10.8.4. Company Revenue and Product Analysis
10.8.5. APAC Segment – Product type and Application Market Size
10.8.5.1. China 
10.8.5.2. Australia
10.8.5.3. Japan 
10.8.5.4. South Korea
10.8.5.5. India
10.8.5.6. Taiwan
10.8.5.7. Malaysia
11. Oncology Market - Entropy
11.1. New product launches
11.2. M&A's, collaborations, JVs and partnerships
12. Oncology Market – Industry / Segment Competition landscape Premium
12.1. Market Share Analysis
12.1.1. Market Share by Country- Top companies
12.1.2. Market Share by Region- Top 10 companies
12.1.3. Market Share by type of Application – Top 10 companies
12.1.4. Market Share by type of Product / Product category- Top 10 companies
12.1.5. Market Share at global level- Top 10 companies
12.1.6. Best Practises for companies
13. Oncology Market – Key Company List by Country Premium
14. Oncology Market Company Analysis
14.1. Market Share, Company Revenue, Products, M&A, Developments
14.2. Aegerion Pharmaceuticals, INC.
14.3. AbbVie
14.4. Ability Pharma
14.5. ACADIA PHARMACEUTICALS
14.6. Amgen Inc.
14.7. Ariad Pharmaceuticals
14.8. Aslan Pharmaceuticals
14.9. Aspen
14.10. AstraZeneca
14.11. Athenex
14.12. Company 11
14.13. Company 12 and more
"*Financials would be provided on a best efforts basis for private companies"
15. Oncology Market -Appendix
15.1. Abbreviations
15.2. Sources
16. Oncology Market -Methodology Premium
16.1. Research Methodology
16.1.1. Company Expert Interviews
16.1.2. Industry Databases
16.1.3. Associations
16.1.4. Company News
16.1.5. Company Annual Reports
16.1.6. Application Trends
16.1.7. New Products and Product database
16.1.8. Company Transcripts
16.1.9. R&D Trends
16.1.10. Key Opinion Leaders Interviews
16.1.11. Supply and Demand Trends
List of Tables

Table 1: Oncology Market Overview 2019-2024
Table 2: Oncology Market Leader Analysis 2018-2019 (US$)
Table 3: Oncology Market Product Analysis 2018-2019 (US$)
Table 4: Oncology Market End User Analysis 2018-2019 (US$)
Table 5: Oncology Market Patent Analysis 2013-2018* (US$)
Table 6: Oncology Market Financial Analysis 2018-2019 (US$)
Table 7: Oncology Market Driver Analysis 2018-2019 (US$)
Table 8: Oncology Market Challenges Analysis 2018-2019 (US$)
Table 9: Oncology Market Constraint Analysis 2018-2019 (US$)
Table 10: Oncology Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Oncology Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Oncology Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Oncology Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Oncology Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Oncology Market Value Chain Analysis 2018-2019 (US$)
Table 16: Oncology Market Pricing Analysis 2019-2024 (US$)
Table 17: Oncology Market Opportunities Analysis 2019-2024 (US$)
Table 18: Oncology Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Oncology Market Supplier Analysis 2018-2019 (US$)
Table 20: Oncology Market Distributor Analysis 2018-2019 (US$)
Table 21: Oncology Market Trend Analysis 2018-2019 (US$)
Table 22: Oncology Market Size 2018 (US$)
Table 23: Oncology Market Forecast Analysis 2019-2024 (US$)
Table 24: Oncology Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Oncology Market, Revenue & Volume, BY CANCER TYPE, 2019-2024 ($)
Table 26: Oncology Market BY CANCER TYPE, Revenue & Volume, By Breast Cancer, 2019-2024 ($)
Table 27: Oncology Market BY CANCER TYPE, Revenue & Volume, By Lung Cancer, 2019-2024 ($)
Table 28: Oncology Market, Revenue & Volume, BY THERAPY TYPE, 2019-2024 ($)
Table 29: Oncology Market BY THERAPY TYPE, Revenue & Volume, By Medical Oncology, 2019-2024 ($)
Table 30: North America Oncology Market, Revenue & Volume, BY CANCER TYPE, 2019-2024 ($)
Table 31: North America Oncology Market, Revenue & Volume, BY THERAPY TYPE, 2019-2024 ($)
Table 32: South america Oncology Market, Revenue & Volume, BY CANCER TYPE, 2019-2024 ($)
Table 33: South america Oncology Market, Revenue & Volume, BY THERAPY TYPE, 2019-2024 ($)
Table 34: Europe Oncology Market, Revenue & Volume, BY CANCER TYPE, 2019-2024 ($)
Table 35: Europe Oncology Market, Revenue & Volume, BY THERAPY TYPE, 2019-2024 ($)
Table 36: APAC Oncology Market, Revenue & Volume, BY CANCER TYPE, 2019-2024 ($)
Table 37: APAC Oncology Market, Revenue & Volume, BY THERAPY TYPE, 2019-2024 ($)
Table 38: Middle East & Africa Oncology Market, Revenue & Volume, BY CANCER TYPE, 2019-2024 ($)
Table 39: Middle East & Africa Oncology Market, Revenue & Volume, BY THERAPY TYPE, 2019-2024 ($)
Table 40: Russia Oncology Market, Revenue & Volume, BY CANCER TYPE, 2019-2024 ($)
Table 41: Russia Oncology Market, Revenue & Volume, BY THERAPY TYPE, 2019-2024 ($)
Table 42: Israel Oncology Market, Revenue & Volume, BY CANCER TYPE, 2019-2024 ($)
Table 43: Israel Oncology Market, Revenue & Volume, BY THERAPY TYPE, 2019-2024 ($)
Table 44: Top Companies 2018 (US$)Oncology Market, Revenue & Volume
Table 45: Product Launch 2018-2019Oncology Market, Revenue & Volume
Table 46: Mergers & Acquistions 2018-2019Oncology Market, Revenue & Volume


List of Figures

Figure 1: Overview of Oncology Market 2019-2024
Figure 2: Market Share Analysis for Oncology Market 2018 (US$)
Figure 3: Product Comparison in Oncology Market 2018-2019 (US$)
Figure 4: End User Profile for Oncology Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Oncology Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Oncology Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Oncology Market 2018-2019
Figure 8: Ecosystem Analysis in Oncology Market 2018
Figure 9: Average Selling Price in Oncology Market 2019-2024
Figure 10: Top Opportunites in Oncology Market 2018-2019
Figure 11: Market Life Cycle Analysis in Oncology Market
Figure 12: GlobalBY CANCER TYPEOncology Market Revenue, 2019-2024 ($)
Figure 13: GlobalBY THERAPY TYPEOncology Market Revenue, 2019-2024 ($)
Figure 14: Global Oncology Market - By Geography
Figure 15: Global Oncology Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 16: Global Oncology Market CAGR, By Geography, 2019-2024 (%)
Figure 17: North America Oncology Market Value & Volume, 2019-2024 ($)
Figure 18: US Oncology Market Value & Volume, 2019-2024 ($)
Figure 19: US GDP and Population, 2018-2019 ($)
Figure 20: US GDP – Composition of 2018, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2018-2019 ($)
Figure 22: Canada Oncology Market Value & Volume, 2019-2024 ($)
Figure 23: Canada GDP and Population, 2018-2019 ($)
Figure 24: Canada GDP – Composition of 2018, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26: Mexico Oncology Market Value & Volume, 2019-2024 ($)
Figure 27: Mexico GDP and Population, 2018-2019 ($)
Figure 28: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30: South America Oncology Market Value & Volume, 2019-2024 ($)
Figure 31: Brazil Oncology Market Value & Volume, 2019-2024 ($)
Figure 32: Brazil GDP and Population, 2018-2019 ($)
Figure 33: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35: Venezuela Oncology Market Value & Volume, 2019-2024 ($)
Figure 36: Venezuela GDP and Population, 2018-2019 ($)
Figure 37: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39: Argentina Oncology Market Value & Volume, 2019-2024 ($)
Figure 40: Argentina GDP and Population, 2018-2019 ($)
Figure 41: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43: Ecuador Oncology Market Value & Volume, 2019-2024 ($)
Figure 44: Ecuador GDP and Population, 2018-2019 ($)
Figure 45: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47: Peru Oncology Market Value & Volume, 2019-2024 ($)
Figure 48: Peru GDP and Population, 2018-2019 ($)
Figure 49: Peru GDP – Composition of 2018, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51: Colombia Oncology Market Value & Volume, 2019-2024 ($)
Figure 52: Colombia GDP and Population, 2018-2019 ($)
Figure 53: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55: Costa Rica Oncology Market Value & Volume, 2019-2024 ($)
Figure 56: Costa Rica GDP and Population, 2018-2019 ($)
Figure 57: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59: Europe Oncology Market Value & Volume, 2019-2024 ($)
Figure 60: U.K Oncology Market Value & Volume, 2019-2024 ($)
Figure 61: U.K GDP and Population, 2018-2019 ($)
Figure 62: U.K GDP – Composition of 2018, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64: Germany Oncology Market Value & Volume, 2019-2024 ($)
Figure 65: Germany GDP and Population, 2018-2019 ($)
Figure 66: Germany GDP – Composition of 2018, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68: Italy Oncology Market Value & Volume, 2019-2024 ($)
Figure 69: Italy GDP and Population, 2018-2019 ($)
Figure 70: Italy GDP – Composition of 2018, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72: France Oncology Market Value & Volume, 2019-2024 ($)
Figure 73: France GDP and Population, 2018-2019 ($)
Figure 74: France GDP – Composition of 2018, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2018-2019 ($)
Figure 76: Netherlands Oncology Market Value & Volume, 2019-2024 ($)
Figure 77: Netherlands GDP and Population, 2018-2019 ($)
Figure 78: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80: Belgium Oncology Market Value & Volume, 2019-2024 ($)
Figure 81: Belgium GDP and Population, 2018-2019 ($)
Figure 82: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84: Spain Oncology Market Value & Volume, 2019-2024 ($)
Figure 85: Spain GDP and Population, 2018-2019 ($)
Figure 86: Spain GDP – Composition of 2018, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88: Denmark Oncology Market Value & Volume, 2019-2024 ($)
Figure 89: Denmark GDP and Population, 2018-2019 ($)
Figure 90: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92: APAC Oncology Market Value & Volume, 2019-2024 ($)
Figure 93: China Oncology Market Value & Volume, 2019-2024
Figure 94: China GDP and Population, 2018-2019 ($)
Figure 95: China GDP – Composition of 2018, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2018-2019 ($)Oncology Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 97: Australia Oncology Market Value & Volume, 2019-2024 ($)
Figure 98: Australia GDP and Population, 2018-2019 ($)
Figure 99: Australia GDP – Composition of 2018, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101: South Korea Oncology Market Value & Volume, 2019-2024 ($)
Figure 102: South Korea GDP and Population, 2018-2019 ($)
Figure 103: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105: India Oncology Market Value & Volume, 2019-2024 ($)
Figure 106: India GDP and Population, 2018-2019 ($)
Figure 107: India GDP – Composition of 2018, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2018-2019 ($)
Figure 109: Taiwan Oncology Market Value & Volume, 2019-2024 ($)
Figure 110: Taiwan GDP and Population, 2018-2019 ($)
Figure 111: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113: Malaysia Oncology Market Value & Volume, 2019-2024 ($)
Figure 114: Malaysia GDP and Population, 2018-2019 ($)
Figure 115: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117: Hong Kong Oncology Market Value & Volume, 2019-2024 ($)
Figure 118: Hong Kong GDP and Population, 2018-2019 ($)
Figure 119: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121: Middle East & Africa Oncology Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 122: Russia Oncology Market Value & Volume, 2019-2024 ($)
Figure 123: Russia GDP and Population, 2018-2019 ($)
Figure 124: Russia GDP – Composition of 2018, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126: Israel Oncology Market Value & Volume, 2019-2024 ($)
Figure 127: Israel GDP and Population, 2018-2019 ($)
Figure 128: Israel GDP – Composition of 2018, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130: Entropy Share, By Strategies, 2018-2019* (%)Oncology Market
Figure 131: Developments, 2018-2019*Oncology Market
Figure 132: Company 1 Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 133: Company 1 Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134: Company 1 Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 135: Company 2 Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 2 Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 2 Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 3 Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 3 Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 3 Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 4 Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 4 Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 4 Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 5 Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 5 Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 5 Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 6 Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 6 Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 6 Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 7 Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 7 Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 7 Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 8 Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 8 Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 8 Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 9 Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 9 Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 9 Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 10 Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 10 Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 10 Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 11 Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 11 Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 11 Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 12 Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 12 Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 12 Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 13 Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 13 Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 13 Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 14 Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 14 Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 14 Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 15 Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 15 Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 15 Oncology Market Net Sales Share, By Geography, 2018 (%)